abstract |
C:WRPertblxOCCk\DARW79J71_l.DOC-I]/I1211I1 Biomarker signatures, including clusterin, were identified which can be used to diagnose or predict kidney or liver toxicity and more specifically renal toxicity as a consequence of disease or drug treatment. |